MacroGenics, Inc. (MGNX): Price and Financial Metrics
MGNX Price/Volume Stats
Current price | $2.87 | 52-week high | $21.88 |
Prev. close | $2.98 | 52-week low | $2.79 |
Day low | $2.86 | Volume | 52,668 |
Day high | $3.00 | Avg. volume | 614,493 |
50-day MA | $3.24 | Dividend yield | N/A |
200-day MA | $4.60 | Market Cap | 180.13M |
MGNX Stock Price Chart Interactive Chart >
MacroGenics, Inc. (MGNX) Company Bio
Macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company was founded in 2000 and is based in Rockville, Maryland.
MGNX Price Returns
1-mo | -15.84% |
3-mo | -34.02% |
6-mo | -18.47% |
1-year | -83.53% |
3-year | -75.84% |
5-year | -69.82% |
YTD | -11.69% |
2024 | -66.22% |
2023 | 43.37% |
2022 | -58.19% |
2021 | -29.79% |
2020 | 110.11% |
Continue Researching MGNX
Want to do more research on Macrogenics Inc's stock and its price? Try the links below:Macrogenics Inc (MGNX) Stock Price | Nasdaq
Macrogenics Inc (MGNX) Stock Quote, History and News - Yahoo Finance
Macrogenics Inc (MGNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...